2-Bromo-4-methylthiazole-5-carboxylic acid, 95.0%, 1g

tert-Butyl 2-oxopyrrolidine-1-carboxylate, 99.00%, 5g

1-(5-Nonyl)piperazine, 98.0%, 1g

1,2,6,7-Tetrahydro-8H-indeno[5,4-b]furan-8-one, 95.0%, 5g

4-Aminoisoindolin-1-one, 95.0%, 10g

5-Cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazole-4-carboxylic acid, 96%, 250mg

(R)-2-((tert-Butoxycarbonyl)amino)-5-(cyclohexyloxy)-5-oxopentanoic acid, 95.0%, 25g

Methyl 4-(1-methoxy-1-oxopent-4-yn-2-yl)benzoate, 97%, 1g

Recipiente di reazione a flangia piatta cilindrico, graduato (1) Fondo tondo, DN 100, 105 mm, Altezza, 140 mm, 1 Pezzo

4-Chloro-1,3-dimethyl-1H-pyrazole-5-carboxylic acid hydrazide, 1g

(S)-tert-Butyl (1-(4-(benzyloxy)phenyl)-4-chloro-3-oxobutan-2-yl)carbamate, 97%, 5g

ethyl 8-(3-methylphenyl)-8-oxooctanoate, 97.0%, 1g

3,4-Dihydrobenzo[f][1,4]oxazepin-5(2H)-one, 95.0%, 1g